Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Mitch Dowsett ¹, Nicholas Turner ¹

Affiliations

No abstract available

Citedby
TAILORx: Questions Answered, Lessons Learned, and Remaining Knowledge Gaps. Joseph A Sparano, Robert Gray. J Clin Oncol, 2019 Jun 08; 37(21). PMID: 31173552 Free PMC article.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge. less N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962 Free PMC article. Highly Cited.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet? A Matikas, T Foukakis, S Swain, J Bergh. Ann Oncol, 2019 May 28; 30(7). PMID: 31131397 Free PMC article. Review.
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer. Jinani Jayasekera, Joseph A Sparano, +5 authors, Jeanne Mandelblatt. less JNCI Cancer Spectr, 2020 Apr 28; 3(4). PMID: 32337487 Free PMC article.
Management of early breast cancer during the COVID-19 pandemic in Brazil. Francisco Pimentel Cavalcante, Guilherme Garcia Novita, +4 authors, Ruffo Freitas Junior. less Breast Cancer Res Treat, 2020 Aug 18; 184(2). PMID: 32803637 Free PMC article.